| Inflammation, atherosclerosis, and coronary artery disease | New England Journal of Medicine | 2005 | 6.3K |
| Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients | Journal of Thrombosis and Haemostasis | 2005 | 2.8K |
| Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement | Cytotherapy | 2005 | 1.4K |
| Cloning of a human parvovirus by molecular screening of respiratory tract samples | Proceedings of the National Academy of Sciences of the United States of America | 2005 | 1.2K |
| Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model | International Journal of Pharmaceutics | 2005 | 636 |
| IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly | Kidney International | 2005 | 588 |
| Temporal changes in whole-blood and plasma glutathione in ICU patients with multiple organ failure | Intensive Care Medicine | 2005 | 539 |
| RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages | Scandinavian Journal of Immunology | 2005 | 404 |
| Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence | Cancer | 2005 | 364 |
| Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology | Clinical Chemistry | 2005 | 358 |
| Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells | Journal of Experimental Medicine | 2005 | 356 |
| Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock | Critical Care Medicine | 2005 | 345 |
| Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta | Transplantation | 2005 | 344 |
| Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden | Arthritis and Rheumatism | 2005 | 334 |
| Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists | Annals of the Rheumatic Diseases | 2005 | 296 |
| Adipocyte lipases and defect of lipolysis in human obesity | Diabetes | 2005 | 293 |
| The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients | Journal of Immunology | 2005 | 282 |
| In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem) | Journal of Infectious Diseases | 2005 | 279 |
| High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study | Gastroenterology | 2005 | 276 |
| Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists | Annals of the Rheumatic Diseases | 2005 | 268 |
| CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice | Hepatology | 2005 | 257 |
| Brain response to putative pheromones in homosexual men | Proceedings of the National Academy of Sciences of the United States of America | 2005 | 251 |
| Human fat cell lipolysis: biochemistry, regulation and clinical role | Best Practice and Research in Clinical Endocrinology and Metabolism | 2005 | 251 |
| Functional studies of mesenchymal stem cells derived from adult human adipose tissue | Experimental Cell Research | 2005 | 245 |
| Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility | Nature Genetics | 2005 | 240 |
